Real-world data analysis of potential drug-drug interactions in Greek community pharmacies

被引:0
|
作者
Poulentzas, Georgios [1 ]
Lalagkas, Panagiotis Nikolaos [1 ]
Tsiolis, Lampros [1 ]
Hadjipavlou-Litina, Dimitra [1 ]
Berberoglou, Eleftherios [2 ]
Douros, Antonios [3 ,4 ,5 ,6 ,7 ,8 ]
Kontogiorgis, Christos [2 ]
Constantinides, Theodoros [2 ]
机构
[1] Aristotle Univ Thessaloniki, Thessaloniki, Greece
[2] Democritus Univ Thrace, Alexandroupolis, Greece
[3] McGill Univ, Montreal, PQ, Canada
[4] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada
[5] Charite Univ Med Berlin, Inst Clin Pharmacol & Toxicol, Berlin, Germany
[6] Free Univ Berlin, Berlin, Germany
[7] Humboldt Univ, Berlin, Germany
[8] Berlin Inst Hlth, Berlin, Germany
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
2330
引用
收藏
页码:170 / 171
页数:2
相关论文
共 50 条
  • [41] An analysis of potential drug-drug interactions in an aging HIV cohort
    Gardiner, P.
    Rizzo, G.
    O'Donovan, M.
    HIV MEDICINE, 2019, 20 : 127 - 127
  • [42] The use of a clinical decision support tool to assess the risk of QT drug-drug interactions in community pharmacies
    Berger, Florine A.
    van der Sijs, Heteen
    van Gelder, Teun
    van den Bemt, Patricia M. L. A.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2021, 12
  • [43] Real-world effect of a potential drug-drug interaction between topiramate and oral contraceptives on unintended pregnancy outcomes
    Sarayani, Amir
    Winterstein, Almut
    Cristofoletti, Rodrigo
    Vozmediano, Valva
    Schmidt, Stephan
    Brown, Joshua
    CONTRACEPTION, 2023, 120
  • [44] Perceptions of community pharmacists of drug-drug interactions
    Dahri, Karen
    Araujo, Louise
    Chen, Si
    Bagri, Harkaryn
    Walia, Keerti
    Lau, Louise
    Legal, Michael
    CANADIAN PHARMACISTS JOURNAL, 2023, 156 (01) : 42 - 48
  • [45] Laboratory Tests in the Clinical Risk Management of Potential Drug-Drug Interactions A Cross-Sectional Study Using Drug-Dispensing Data from 100 Dutch Community Pharmacies
    Geerts, Arjen F. J.
    De Koning, Fred H. P.
    De Smet, Peter A. G. M.
    Van Solinge, Wouter W.
    Egberts, Toine C. G.
    DRUG SAFETY, 2009, 32 (12) : 1189 - 1197
  • [46] Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments
    Fokter, Nina
    Mozina, Martin
    Brvar, Miran
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (3-4) : 81 - 88
  • [47] Drug-Drug Interactions of Selective Serotonin Reuptake Inhibitors: A Pharmacovigilance Study on Real-World Evidence from the EudraVigilance Database
    Dobrea, Carmen Maximiliana
    Frum, Adina
    Butuca, Anca
    Morgovan, Claudiu
    Stoicescu, Laurentiu
    Chis, Adriana Aurelia
    Arseniu, Anca Maria
    Rus, Luca Liviu
    Gligor, Felicia Gabriela
    Vonica-Tincu, Andreea Loredana
    PHARMACEUTICALS, 2024, 17 (10)
  • [48] Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort
    Siederdissen, Christoph Hoener Zu
    Maasoumy, Benjamin
    Marra, Fiona
    Deterding, Katja
    Port, Kerstin
    Manns, Michael P.
    Cornberg, Markus
    Back, David
    Wedemeyer, Heiner
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (05) : 561 - 567
  • [49] Potential Drug-Drug Interactions and Admissions Due to Drug-Drug Interactions in Patients Treated in Medical Departments
    Fokter, N.
    Mozina, M.
    Bone, M.
    Brvar, M.
    CLINICAL TOXICOLOGY, 2009, 47 (05) : 496 - 497
  • [50] Analysis of Drug Authentication at the Point of Dispensing in Belgian and Greek Community Pharmacies
    Simoens, Steven
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (10) : 1701 - 1706